Table 2.
Patient characteristic | N = 162 |
---|---|
Age (years), range 44–100, mean ± SD | 69 ± 11 |
Male gender: N (%) | 157 (97%) |
Race, white | 117 (72%) |
Primary diagnosis | |
Stroke | 110 (68%) |
Transient ischemic attack | 31 (19%) |
Carotid stenosis | 30 (19%) |
Other | 31 (19%) |
Functional Independence Measure score, range 27–126 (n = 137) | 106.47 ± 20.614.0 |
National Institute of Health Stroke Scale score, range 0–14, mean ± SD | 2.5 ± 3.4 |
Total number of Stroke Clinic visits per patient | |
1 | 94 (58%) |
2 | 41 (25%) |
≥3 | 27 (17%) |
Number of comorbid conditions | |
1 | 2% |
2 or 3 | 16% |
4 or 5 | 39% |
≥6 | 43% |
Comorbid conditions | |
Stroke | 108 (67%) |
Transient ischemic attack | 37 (23%) |
Hypertension | 130 (80%) |
Hyperlipidemia | 105 (65%) |
Ischemic heart disease | 66 (41%) |
Depression | 57 (35%) |
Diabetes mellitus | 47 (29%) |
Prostatic hypertrophy | 36 (22%) |
Peripheral vascular disease | 33 (20%) |
Peptic ulcer disease | 31 (19%) |
Congestive heart failure | 16 (10%) |
Sleep apnea | 14 (9%) |
New symptom or diagnosis | |
Impaired cognition | 88 (54%) |
Pain | 64 (40%) |
Depression | 56 (35%) |
Impaired sexual functioning | 45 (28%) |
Fall risk | 60 (37%) |
Falls | 29 (18%) |
Dysphagia | 25 (15%) |
Obstructive sleep apnea | 12 (7%) |
Osteopenia/osteoporosis | 10 (6%) |
Peripheral neuropathy | 9 (6%) |
Clinical care changes | |
Service referral made | 90% |
Any rehabilitation | 64 (40%) |
Any psychological therapy | 32 (20%) |
BP clinic | 39 (21%) |
Primary care clinic | 16 (10%) |
Smoking cessation | 22 (14%) |
Pulmonary/sleep study | 51 (31%) |
Diagnostic testing ordered | 88% |
Equipment issued | 48% |
Medication information | |
Medications added | 71 (44%) |
Contraindications to a medication present | 48 (30%) |
Medication dose changed | 43 (27%) |
Medications discontinued | 25 (15%) |
Able to name a stroke sign or symptom at last visit | 10% |
Abbreviations: BP, blood pressure; SD, standard deviation.